Dorimarc 250/500mg INJ

Dorimarc 250/500 mg INJ has broad-spectrum activity against aerobic Gram-negative and Gram-positive and aerobic pathogens. This injection is formulated on Doripenem that is more effective as compared to meropenem against P. aeruginosa. John et. al. Isolates of A. baumannii and isolates of P. aeruginosa which are resistant to meropenem and sensitive to doripenem. P. aeruginosa showed a sensitivity of 60.3% for doripenem and 44.8% for meropenem.